June 10, 2021

Sema4 and CM Life Sciences Announce the Filing of Amended Preliminary Proxy Statement

STAMFORD, Conn.–(BUSINESS WIRE)—- $CMLF #AI–The filing of the amended proxy statement marks the next step in the formal Securities and Exchange Commission (SEC) review process.


Leave Comment


Your Name *
Your Email *
Your Website
Comment *